The current study suggests that the biological consequences of SF3B1 splicing factor mutations may focus on affecting erythropoiesis, iron metabolism homeostasis, high inflammatory environment, and DNA damage to promote the progression of MDS (Supplementary Figure 1). Here, SF3B1 is linked to myelodysplastic syndrome.